Intravenous Insulin in Patients With Diabetes After Percutaneous Coronary Intervention (PCI)

• Status: Terminated
• Trial end date: 2009-04-01
• Target enrollment: 0
• Participant gender: All

Summary

The purpose of this study is to evaluate the effects of intravenous insulin/24 hours to normalize glycemia upon markers of oxidative stress (protein oxidation and total antioxidant defense) and inflammation (C-reactive protein (CRP) and sCD40L) in diabetic patients submitted to PCI with stent.

• Phase: N/A
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Hospital de Clinicas de Porto Alegre
• Collaborators: Conselho Nacional de Desenvolvimento Científico e Tecnológico; FIPE; Fundação de Amparo à Pesquisa do Estado do Rio Grande do Sul, Brazil
• Treatments: Insulin; Insulin, Globin Zinc

Criteria

Inclusion Criteria:

• Patients with Diabetes Mellitus submitted to Percutaneous Coronary Intervention with Stent bare metal

• Age: 18-80 years old

Exclusion Criteria:

• Restenosis

• Drug elution stent

• Acute coronary syndrome at last 30 days

• Use anti inflammatory, antibiotic, vitamin E

• Inflammatory disease or oncologic